Topics

Prosetta Biosciences, Inc. Company Profile

03:05 EST 24th January 2020 | BioPortfolio

Prosetta is a 12-year-old biotechnology company that is dedicated to the discovery, development and commercialization of innovative and cost-effective human and animal treatments and therapeutics. Prosetta applies its proprietary approach to drug discovery, based on over 25 years of research, via cell-free assembly, cellular models, drug-resin affinity chromatography and interactome analysis, that can be applied for purposes of drug discovery across a range of debilitating diseases and disorders.


News Articles [614 Associated News Articles listed on BioPortfolio]

Inflection, AUM Biosciences partner to develop cancer treatments

Inflection Biosciences, an Irish drug developer, has signed an international deal with AUM Biosciences of Singapore for the d -More- 

AUM Biosciences to develop Inflection’s cancer therapy

Biotechnology firm AUM Biosciences has entered a global licence agreement for Inflection Biosciences’ series of PIM/PI3K/mTOR inhibitor molecules. Under the...Read More... The post AUM Biosciences t...

Curriculum Reforms in Uganda Integrate Modern Biosciences

Years of relentless efforts led by Uganda Biosciences Information Center (UBIC) to integrate modern biosciences into Uganda's middle/secondary schools' curriculum were finally rewarded. Uganda's Minis...

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Genocea Biosciences on Top

Last week's top risers were Genocea Biosciences, Outlook Therapeutics, Hoth Therapeutics, Aveo Oncology and Evofem Biosciences. The post 5 Top Weekly NASDAQ Biotech and Pharma Stocks: Genocea Bioscien...

DGAP-News: Isracann Biosciences Inc.: Isracann Biosciences legt israelischer Landesbehörde Pläne für die Cannabisanlage vor (deutsch)

Isracann Biosciences Inc.: Isracann Biosciences legt israelischer Landesbehörde Pläne für die Cannabisanlage vor DGAP-News: Isracann Biosciences Inc. / Schlagwort(e): Expansion Isracann Biosciences...

Therapix Biosciences (NASDAQ: $TRPX) Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction Valuing Therapix at US$48 Million

TEL AVIV, Israel - July 23, 2019 (Investorideas.com Newswire) Therapix Biosciences Ltd. ("Therapix" or "the Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the...

Close of IGM Biosciences' IPO yields $200M

IGM Biosciences' initial public offering closed with gross proceeds of about $201.3 million after it sold approximately 12.6  -More- 

DGAP-News: Isracann Biosciences Inc.: Isracann Biosciences beginnt mit erster Phase des Betriebsentwicklungsprogramms in Israel (deutsch)

Isracann Biosciences Inc.: Isracann Biosciences beginnt mit erster Phase des Betriebsentwicklungsprogramms in Israel DGAP-News: Isracann Biosciences Inc. / Schlagwort(e): Expansion Isracann Bioscie...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Spherusol [nielsen biosciences, inc.]

These highlights do not include all the information needed to use Spherusol safely and effectively. See full prescribing information for Spherusol . Coccidioides immitis Spherule-Derived Skin Test Ant...

Natelle one [azur pharma, inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [52 Associated PubMed Articles listed on BioPortfolio]

Heineken, Tsuchiya and Aris on the Mathematical Status of the Pseudo-steady State Hypothesis: a Classic from Volume 1 of Mathematical Biosciences.

Volume 1, Issue 1 of Mathematical Biosciences was the venue for a now-classic paper on the application of singular perturbation theory in enzyme kinetics, "On the mathematical status of the pseudo-ste...

A genomic extension to the sequence of HLA-A*02:13, identified using Third-Generation Sequencing.

Pacific Biosciences' SMRT sequencing method was used to extend the sequence of HLA-A*02:13. This article is protected by copyright. All rights reserved.

How the diversity of the faces arises.

The evolution of the face is crucial for each species to adapt to different diets, environments, and in some species, to promote social interaction. The diversity in the shapes of the face results fro...

Regulation of IGF-1 by IGFBP3 and IGFBP5 during odontoblast differentiation in mice.

Although intracellular signaling pathways of insulin-like growth factor 1 (IGF-1) related to the proliferation of dental pulp cells have been investigated, the switching mechanism from cell proliferat...

Degradation of extracellular matrices propagates calcification during development and healing in bones and teeth.

Bone, dentin, and enamel are tissues formed through calcification, a process involving deposition of calcium phosphate minerals on extracellular organic matrices. Calcification, the underlying mechani...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer

The drug for this submission is Hope Biosciences' allogeneic, first blood relative, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSCs) for the treatment of a single patien...

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Parkinson's Disease

The drug for this submission is Hope Biosciences' autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC's) for the treatment of a single patient with Parkinson's Di...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Companies [409 Associated Companies listed on BioPortfolio]

Prosetta Biosciences, Inc.

Prosetta is a 12-year-old biotechnology company that is dedicated to the discovery, development and commercialization of innovative and cost-effective human and animal treatments ...

Prosetta Antiviral Inc.

Prosetta is a 9-year-old San Francisco-based biotechnology company with an innovative approach to drug discovery. The Prosetta platform emerged from 25 years of basic research on ...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Prosetta Biosciences, Inc." on BioPortfolio

We have published hundreds of Prosetta Biosciences, Inc. news stories on BioPortfolio along with dozens of Prosetta Biosciences, Inc. Clinical Trials and PubMed Articles about Prosetta Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prosetta Biosciences, Inc. Companies in our database. You can also find out about relevant Prosetta Biosciences, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...


Corporate Database Quicklinks



Searches Linking to this Company Record